Published in Am J Physiol on April 01, 1990
Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest (1992) 2.10
Chronic nitric oxide inhibition model six years on. Hypertension (1998) 1.72
Endothelium-dependent and independent relaxation of the rat aorta by cyclic nucleotide phosphodiesterase inhibitors. Br J Pharmacol (1991) 1.19
Increases in endothelial cyclic AMP levels amplify agonist-induced formation of endothelium-derived relaxing factor (EDRF). Biochem J (1992) 1.07
Cyclic AMP enhances agonist-induced Ca2+ entry into endothelial cells by activation of potassium channels and membrane hyperpolarization. Biochem J (1993) 1.03
Modulation of agonist-induced calcium mobilisation in bovine aortic endothelial cells by phorbol myristate acetate and cyclic AMP but not cyclic GMP. Br J Pharmacol (1991) 0.89
Differential sensitivities of the prostacyclin and nitric oxide biosynthetic pathways to cytosolic calcium in bovine aortic endothelial cells. Br J Pharmacol (1992) 0.82
β₁-Adrenoceptor stimulation suppresses endothelial IK(Ca)-channel hyperpolarization and associated dilatation in resistance arteries. Br J Pharmacol (2013) 0.77
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature (1999) 13.73
Nurses' reports on hospital care in five countries. Health Aff (Millwood) (2001) 7.48
Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature (1999) 4.47
Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation (2004) 3.71
Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res (2001) 3.18
Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension (1986) 2.96
Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett (1990) 2.84
A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res (2000) 2.79
Leptin, the product of Ob gene, promotes angiogenesis. Circ Res (1998) 2.63
Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett (1990) 2.57
Intracellular pH and tyrosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells. Circ Res (1996) 2.56
NG-nitro-L-arginine (N5-[imino(nitroamino)methyl]-L-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from L-arginine. Naunyn Schmiedebergs Arch Pharmacol (1990) 2.55
Modulation of the Ca2 permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium. Circ Res (2005) 2.38
Calcium influx into endothelial cells and formation of endothelium-derived relaxing factor is controlled by the membrane potential. Pflugers Arch (1990) 2.36
Leptin induces oxidative stress in human endothelial cells. FASEB J (1999) 2.32
Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin. Diabetologia (2006) 2.27
Normoxic cardiopulmonary bypass reduces oxidative myocardial damage and nitric oxide during cardiac operations in the adult. J Thorac Cardiovasc Surg (1998) 2.16
Stimulation of soluble guanylate cyclase by an acetylcholine-induced endothelium-derived factor from rabbit and canine arteries. Circ Res (1986) 2.14
Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol (1994) 2.06
Nitric oxide synthesis in endothelial cytosol: evidence for a calcium-dependent and a calcium-independent mechanism. Naunyn Schmiedebergs Arch Pharmacol (1989) 2.03
Generation of nitric oxide by human neutrophils. Biochem Biophys Res Commun (1989) 2.02
Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circulation (1996) 1.98
Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res (2001) 1.94
Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells. Cardiovasc Res (1999) 1.93
Signal transduction of eNOS activation. Cardiovasc Res (1999) 1.92
An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci U S A (2000) 1.89
Endothelial dysfunction in chronic myocardial infarction despite increased vascular endothelial nitric oxide synthase and soluble guanylate cyclase expression: role of enhanced vascular superoxide production. Circulation (1999) 1.89
The role of endothelium in the control of vascular tone. Basic Res Cardiol (1986) 1.78
Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem (1999) 1.78
gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation (2004) 1.77
Ethical issues in funding orphan drug research and development. J Med Ethics (2005) 1.71
LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase. J Pharmacol Exp Ther (1988) 1.71
Differential role of extra- and intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells. Br J Pharmacol (1988) 1.69
Increased free calcium in endothelial cells under stimulation with adenine nucleotides. J Cell Physiol (1986) 1.68
Ultrastructure and molecular histology of rabbit hind-limb collateral artery growth (arteriogenesis). Virchows Arch (2000) 1.68
Phosphorylation and activation of the endothelial nitric oxide synthase by fluid shear stress. Acta Physiol Scand (2000) 1.61
Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes (1999) 1.60
Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase. Circ Res (2001) 1.60
Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res (1995) 1.55
Stimulation of soluble guanylate cyclase by endothelium-derived relaxing factor from cultured endothelial cells. Eur J Pharmacol (1987) 1.53
Endothelium-dependent hyperpolarization of smooth muscle cells in rabbit femoral arteries is not mediated by EDRF (nitric oxide). Naunyn Schmiedebergs Arch Pharmacol (1988) 1.53
Ca2+-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress. Circ Res (1998) 1.50
Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br J Pharmacol (1997) 1.48
NO: the primary EDRF. J Mol Cell Cardiol (1999) 1.46
Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther (2000) 1.44
Prevention of endothelial dysfunction in heart failure by vitamin E: attenuation of vascular superoxide anion formation and increase in soluble guanylyl cyclase expression. Cardiovasc Res (2001) 1.44
Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase. Hypertension (2000) 1.43
A transferable, beta-naphthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells. J Physiol (1996) 1.42
The role of prostaglandins in the endothelium-mediated vasodilatory response to hypoxia. Pflugers Arch (1984) 1.39
Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br J Pharmacol (1994) 1.39
Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-kappaB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation (1997) 1.38
Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension (1991) 1.36
Single nonselective cation channels and Ca2+-activated K+ channels in aortic endothelial cells. J Membr Biol (1987) 1.36
Hypoxia stimulates release of endothelium-derived relaxant factor. Am J Physiol (1989) 1.34
Vasoconstriction and increased flow: two principal mechanisms of shear stress-dependent endothelial autacoid release. Am J Physiol (1993) 1.34
Identification of the neuroeffector transmitter in jejunal branches of the rabbit mesenteric artery. Naunyn Schmiedebergs Arch Pharmacol (1987) 1.32
Activators of potassium channels enhance calcium influx into endothelial cells as a consequence of potassium currents. Naunyn Schmiedebergs Arch Pharmacol (1990) 1.30
S-nitrosation of serum albumin by dinitrosyl-iron complex. J Biol Chem (1995) 1.30
Prostacyclin-induced vasodilation in rabbit heart is mediated by ATP-sensitive potassium channels. Am J Physiol (1993) 1.29
Modulation of the vasodilator action of SIN-1 by the endothelium. J Cardiovasc Pharmacol (1989) 1.29
Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production. Hypertension (1997) 1.26
Mechanical deformation of vessel wall and shear stress determine the basal release of endothelium-derived relaxing factor in the intact rabbit coronary vascular bed. Circ Res (1992) 1.26
What is 'best practice' in health care? State of the art and perspectives in improving the effectiveness and efficiency of the European health care systems. Health Policy (2001) 1.25
Induction and activity of NO synthase in bone-marrow-derived macrophages are independent of Ca2+. Biochem J (1990) 1.24
Nifedipine increases cytochrome P4502C expression and endothelium-derived hyperpolarizing factor-mediated responses in coronary arteries. Hypertension (2000) 1.23
Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. Biochem Biophys Res Commun (1999) 1.22
Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase. Hypertension (2000) 1.21
Calcium signaling in endothelial cells involves activation of tyrosine kinases and leads to activation of mitogen-activated protein kinases. Circ Res (1995) 1.20
Interleukin 1 beta and tumour necrosis factor alpha induce a macrophage-type of nitric oxide synthase in rat renal mesangial cells. Eur J Biochem (1992) 1.20
Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production. Cardiovasc Res (1998) 1.18
Species-dependent differences in the nature of endothelium-derived vascular relaxing factor. Eur J Pharmacol (1984) 1.17
Isometric contraction induces the Ca2+-independent activation of the endothelial nitric oxide synthase. Proc Natl Acad Sci U S A (1999) 1.15
The primary structure of the 70 kDa subunit of bovine soluble guanylate cyclase. FEBS Lett (1988) 1.15
The effect of peroxynitrite on the catalytic activity of soluble guanylyl cyclase. Free Radic Biol Med (2001) 1.14
Subcellular localization and characterization of nitric oxide synthase(s) in endothelial cells: physiological implications. Biochem J (1994) 1.14
Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase. Br J Pharmacol (1998) 1.14
Intracellular alkalinization induced by bradykinin sustains activation of the constitutive nitric oxide synthase in endothelial cells. Circ Res (1994) 1.13
The coronary endothelium-derived hyperpolarizing factor (EDHF) stimulates multiple signalling pathways and proliferation in vascular cells. Pflugers Arch (2001) 1.13
Subcellular localization and characterization of neuronal nitric oxide synthase. J Neurochem (1994) 1.11
Inhibitors of acyl-coenzyme A:lysolecithin acyltransferase activate the production of endothelium-derived vascular relaxing factor. J Pharmacol Exp Ther (1986) 1.10
Oxidized low density lipoproteins potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle. Circ Res (1990) 1.09
Endothelial cells are involved in the vasodilatory response to hypoxia. Pflugers Arch (1983) 1.09
LY 83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator-induced cyclic GMP increases and inhibition of platelet activation. Naunyn Schmiedebergs Arch Pharmacol (1989) 1.08
Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arterioscler Thromb (1991) 1.08
Diethyldithiocarbamate inhibits induction of macrophage NO synthase. FEBS Lett (1993) 1.07
Inhibition of arginase by NG-hydroxy-L-arginine in alveolar macrophages: implications for the utilization of L-arginine for nitric oxide synthesis. FEBS Lett (1995) 1.06